**REGISTERED COMPANY NUMBER: 07877025 (England and Wales) REGISTERED CHARITY NUMBER: 1150183**
## **REPORT OF THE TRUSTEES AND**
**UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023**
## **FOR**
## **NATIONAL HEREDITARY BREAST CANCER HELPLINE (A COMPANY LIMITED BY GUARANTEE)**
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023**
|||**Page**||
|---|---|---|---|
|**Reference and Administrative Details**||1||
|**Report of the Trustees**|2|to|7|
|**Independent Examiner's Report**||8||
|**Statement of Financial Activities**||9||
|**Balance Sheet**|10|to|11|
|**Cash Flow Statement**||12||
|**Notes to the Cash Flow Statement**||13||
|**Notes to the Financial Statements**|14|to|22|
|**Detailed Statement of Financial Activities**|23|to|24|
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
**REFERENCE AND ADMINISTRATIVE DETAILS FOR THE YEAR ENDED 31 MARCH 2023**
**TRUSTEES** G Anderson Policeman A P D Fewings Retired W J Watson Helpline Manager J V Squires Retired **REGISTERED OFFICE** Unit 71 Storforth Lane Trading Estate Storforth Lane Hasland Chesterfield Derbyshire S41 0QZ **REGISTERED COMPANY** 07877025 (England and Wales) **NUMBER REGISTERED CHARITY** 1150183 **NUMBER INDEPENDENT EXAMINER** Marriott Gibbs Rees Wallis Limited Chartered Certified Accountants First Floor Unit 4, Broadfield Court Sheffield South Yorkshire S8 0XF
Page 1
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
## **OBJECTIVES AND ACTIVITIES Objectives and aims**
The charity's objective is to promote and protect good health and relieve sickness for the public benefit by:1. Operating, organising, managing and promoting an association for the training and/or education and/or general advice into all areas of hereditary breast cancer;
2. Managing a national helpline for the delivery of advice into all areas of hereditary breast cancer; and
3. Helping and supporting anyone concerned about their increased risk of developing cancer due to family history.
4. Providing the social network facility of support as this now seems to be an important signpost route that people rely upon.
In order to achieve this objective the charity has opened charity shops, which also act as community support and information centres, providing support to patients and families affected by hereditary cancer via discussion with volunteers and provision of resources. Signposting to all our facilities
This will also raise community awareness of hereditary cancer to promote early detection and management.
The charity will continue to make use of the 45 existing support groups set up by Wendy Watson who will attend meetings wherever possible; although since the pandemic the groups have been much more active online and remained that way. The Leicester Birmingham group is very active in actual face to face meetings - approximately every 6-8 weeks on a Sunday lunchtime. Each group is made up of an average of 50 volunteers and 2 or 3 administrators with the aim to build links with their local genetic services. This is proving very successful so far, with most geneticists adhering to NICE Guidelines on familial breast cancer and providing their patients with contact details of the Helpline and its support groups. The extra group - Tamoxifen and Side Effects which was added 3 years ago devised due to the pandemic reducing access to genetic services, testing, and surgical intervention. This group has continued to expand during 22/23 and accepts new requests to join on a daily basis. It has become an important feature of the Helpline facilities.
The charity continues to build links to encourage triangulation between clinicians, patients and researchers. This will improve the governance and focus of future research.
In determining the charities objectives and planning, its activities the trustees have had due regard for the guidance published by the Charity Commission for public benefit. The overwhelming letters and testimonials from users leaves one in no doubt of the benefits received.
Page 2
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
## **OBJECTIVES AND ACTIVITIES**
## **Significant activities**
The helpline service is available 24hrs every day through social media, and 9am until 8pm by telephone. Emails are answered throughout a 24 hour period. The Helpline has identified other volunteers by way of training courses to help lead other groups around the UK.
The helpline continued its activities throughout 2022/23. Its role still of paramount importance to those using it, even more so due to the lack of NHS services available, and the backlog that has resulted through the pressures on all services. We had expert advice and governance 24/7 available from Prof Gareth Evans, Prof Julian Barwell and also additional guidance from surgeon Lester Barr, a former trustee and chair of The Genesis Appeal.
Psychological assessments are also taking far too long through the NHS - up to 2 years in some areas. This has in some cases resulted in breast cancer being contracted and people actually dying. Such an unacceptable situation needed action; and the charity has enlisted the help of Cath Parfitt, Masters degree in Counselling who also has a history of a BRCA fault in her Husband's family and therefore her children. These assessments are being undertaken within 2 weeks from referral to report. NICE guidelines have also not been adhered to and the Helpline is working to ensure this practice becomes robust - given the millions of pounds and valuable hours put into this guidance.
Other campaigns and the helpline continued, ably supported by the extra efforts of our professional advisors and fully trained staff members who took the reins whilst the previous mainstay of the charity, Wendy, had the debilitating (but benign) huge brain tumour removed.
National Hereditary Breast Cancer Helpline still operate several charity shops throughout the country.
## **Public benefit**
The Trustees confirm that they have complied with the requirements of section 4 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Work done over the years by the helpline founder shows how many millions of pounds have been saved by; 1) Campaigning for recognition of these gene faults; and
2) Spearheading the campaign against the patenting of the genes in the European Parliament.
The work is not restricted to these two components but they have had the most considerable impact. Campaigns for NICE guidelines to be debated and adopted to ensure equality of service for all.
Further information can be found on our website:http://www.breastcancergenetics.co.uk/helpline-achievements/
## **Volunteers**
The charity had help from over 300 volunteers, covering the charity shops and 45 support groups.
The Charity is extremely fortunate to have the strong support of three world renowned advisors.
Wendy Watson MBE continues to provide peer support to all on a voluntary basis. Details of remuneration received for Wendy Watson's role as Helpline Advisor can be found in Note 8.
The two professional medical advisors act voluntarily. These two advisors have been key to the service long before it became a registered charity. They, along with Wendy, continue to be influential worldwide.
Page 3
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
## **ACHIEVEMENT AND PERFORMANCE**
## **Charitable activities**
The charity has maintained its six charity shops and information centres. It has always been intended to run the charity shops and for them to have the means of funding themselves as self-supporting information centres.
The Helpline is a valuable resource for all, with GP's calling as well as the general public. Ongoing training is supplied to staff by Prof Barwell.
The support groups were being run as online meetings in replacement of face-to-face meetings due to social restrictions, and Wendy has headed several webinar online help sessions during lockdowns. The opportunity to meet and speak face to face with other who have gone through similar experiences had long been recognised for its importance by geneticists across the UK and echoed in NICE Guidelines.
A support group was formed to help support people with questions over any potential side effects and concerns of Tamoxifen. Wendy received excellent support letters from both medical advisors congratulating her on 'selfless' work whilst public services were on hold and unavailable.
## **Fundraising activities**
The charity shops continue to receive a steady volume of donations. All contributions are completely voluntary and are very gratefully received.
We have a fundraising partnership with Skycycle Limited. Charity bags are distributed in license areas and filled with unwanted shoes, clothing, toys and bric a brac. The charity receive £75 for every tonne that Skycycle sell from house-to-house collections and £120 for every tonne collected from clothing banks. We also have a further partner, MV clothing who are contributing £18k per annum.
We have also joined the Fundraising Regulator.
## **Investment performance**
The charity has no investments.
## **Internal and external factors**
The information sections within the charity shops and continuously improved and updated. A large proportion of shop space is allocated to giving information and charity shops are used for regular drop in sessions to give advice. The charity shops running costs continue to be apportioned as 50% fundraising and 50% charitable activity.
## **FINANCIAL REVIEW**
## **Financial position**
At 31 March 2023 the charity had unrestricted surplus funds of £102,434 (2022: £120,472).
## **Principal funding sources**
The principal source of funding for the charity is charity shop income. The charity also benefits from donations and the continued goodwill of the public.
Shop income increased during the year however overall income was lower following the removal of Covid support grants.
## **Investment policy and objectives**
The charity does not hold any investments.
## **Reserves policy**
The charity does not have an official policy amount as due to extreme circumstances it is difficult to project future needs, however the bank balances are usually at least £10k in credit.
Page 4
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
## **FINANCIAL REVIEW**
## **Going concern**
Queries are answered by two of the world's respected medical advisors. The charitable activities are currently carried out by these experts in a voluntary capacity. The results are of course unparalleled. Patients are enabled to access referrals wrongly denied by uneducated medics. Support is always on hand by the lead helpline advisor, Wendy Watson MBE, who has global experience in this field. Wendy has advised and lectured professionals across Europe and the USA.
The charity is reliant on ongoing trading activities and donations for its continued existence. Total charity shop income in 2023 was £296,705 which is back to the pre-Covid level of income. The donations of clothing, furniture and electricals are now in abundance with sufficient to stock the shops for many years to come. The lowering of the Central costs and utilisation of the warehouse as a 'shop' open to the public has significantly improved the charity's financial performance.
The information centres only need to be self supporting as our main charitable aim is to provide a service - not to raise monetary donations. They are self supporting by selling charity goods in the same vein as charity shops. We will continue to assess our remaining information centres/charity shop outlets for viability. For any sites continually losing money we shall consider closure, hence making the whole venture more stable and profitable.
The charity suffered a deficit during the year which has led to delays in paying HMRC and our other creditors. The charity financial position has improved since the year end and the trustees believe that the charity can produce a surplus going forward. Consequently, the accounts have been prepared on a going concern basis.
## **FUTURE PLANS**
Our continued objectives and aims are to raise awareness of hereditary breast cancer and reduce mortality. We also will give support to those who find themselves at risk due to family history. The choices are stark; do nothing, be screened regularly, or opt for elective surgery. That option is the only near sure fire way of preventing breast cancer in those at risk.
## **Activities planned to achieve aims**
The charity ball was held on 21 April 2023 to coincide with celebrations of 30 years of Wendy Watson's successful surgery. We usually host a charity ball every year.
We continued to monitor the number of charity shops outlets and their profitability, hence making the whole venture more stable and profitable. At the end of 2023 our venues are:
Rotherham Matlock Morley Ilkeston Doncaster Hasland Warehouse
The charity will receive £18,000 income next year from MV Clothing.
Page 5
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
## **FUTURE PLANS**
Activities planned to achieve aims (continued)
Group support meetings will continue to be held and attended by a core group of people. The meetings welcome new members who are preparing to start their journey. Discussions are always informal around all aspects - most significantly impending surgery. It is of great importance for people to have the opportunity to speak to others who have already been through the process and can share their experiences.
Indeed this 'need' was highlighted as number 2 key priority for adoption in the recent NICE Guideline update on familial breast cancer. Helpline founder Wendy Watson always attends to be on hand with any queries or difficulties.
The charity have recently received extra support from Professor James Coyne of the University of Penn.
We have already made a series of podcasts to cover all aspects of hereditary breast cancer introduced by all the top professionals. The plan is to continue with the podcasts which all feature Wendy Watson and Rebecca Measures, entitled Mother/Daughter - Breast of Friends. The podcasts are made with no cost to the charity, save for the follow up printed materials added to our shops as part of the information service.
A series of podcasts to raise awareness in the 97% of the population has also uncovered many startling facts. Notably Coleen Nolan's family were tested in 2009. Found not to have a fault in BRCA1&2. Tragically 60,000 people were tested negative who should now be recalled for panel tests. The Helpline has made it their mission to alert everyone as this is not protocol with either GPs or genetic departments.
A docu/drama has been commissioned for Channel 4 on Wendy's life. A musical has been commissioned - with West End connections on Wendy's life. This is a lively comedic but informative way to raise awareness in the populus.
Wendy has been invited to be the UK patient representative for a new form of breast screening called Mammowave. Mammowave is a clinical trial running for a further 4 years in UK hospitals and running alongside trials in Italy, Portugal, Spain, France and a few other European countries.
Prof James Coyne, Emeritus Professor of Psychology in the USA has also asked for Wendy Watsons and the Helpline's assistance in obtaining funding in the USA for a similar incentive. Wendy started this up initially in 200 and they have asked for permission to use our videos to get further funding.
The charity will continue to offer the services of a fully trained (Masters degree) counsellor, and hope to benefit greatly from the extra publicity in 2023/24.
## **STRUCTURE, GOVERNANCE AND MANAGEMENT**
## **Governing document and charity constitution**
The organisation is a company limited by guarantee, incorporated on 9 December 2011 and registered with the charities commission on 14 December 2012 as amended by special resolution registered at Companies House on 11 December 2012.
The company was established under a Memorandum of Articles, which established the objects and powers of the charitable company and is governed under its Articles of Association.
## **Recruitment and appointment of new trustees**
The current Trustees are detailed on the reference page. If recruitment is required this will follow the policy and procedures to ensure that all legal and good practice requirements are met.
To enhance the work of the charity, the trustees appointed would have an interest in the work being conducted into Hereditary Breast Cancer.
## **Organisational structure**
The trustees are responsible for the overall management and control of the charity. They are grateful to the many volunteers who give their time to the charity to enable it to be successful in fulfilling its objectives.
The Trustees believe that the organisation is well placed to fulfil the objectives of the charity into the future.
Page 6
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2023**
## **STRUCTURE, GOVERNANCE AND MANAGEMENT**
## **Induction and training of new trustees**
Any new Trustees are given details of the rules and objectives of the charity.
They are invited to work in the central distribution centre and meet some of the volunteers, together with attending meetings held by the support groups.
## **Key management remuneration**
Key management includes Wendy Watson and all trustees. Wendy Watson was working on a self-employed consultancy basis until July 2021. Details of trustees' payments are included in Note 8.
No other trustees received remuneration in the period.
## **Key changes in management and trustees**
There are currently 4 appointed trustees as at the accounts sign off date, John Squires, Grant Anderson, Adrian Fewings and Wendy Watson.
This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.
Approved by order of the board of trustees on 31 January 2024 and signed on its behalf by:
J V Squires - Trustee
Page 7
## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **Independent examiner's report to the trustees of National Hereditary Breast Cancer Helpline ('the Company')**
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023.
## **Responsibilities and basis of report**
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
## **Independent examiner's statement**
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Alan Pickstone FCCA The Association of Chartered Certified Accountants
Marriott Gibbs Rees Wallis Limited Chartered Certified Accountants First Floor Unit 4, Broadfield Court Sheffield South Yorkshire S8 0XF
31 January 2024
Page 8
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2023**
|**2023**
**Unrestricted**
**fund**
Notes
**£**
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
2
**8,220**
Other trading activities
3
**296,705**
Other income
4
**19,922**
**Total**
**324,847**
**EXPENDITURE ON**
Raising funds
5
**198,523**
**Charitable activities**
6
Helpline costs
**3,342**
Campaigning and raising awareness
**133,575**
Activity support costs
**7,445**
**Total**
**342,885**
**NET INCOME/(EXPENDITURE)**
**(18,038)**
**RECONCILIATION OF FUNDS**
Total funds brought forward
**120,472**
**TOTAL FUNDS CARRIED FORWARD**
**102,434**|2022
Total
funds
£
1,525
276,943
62,161|
|---|---|
||340,629|
||182,826
4,159
117,138
19,028|
||323,151|
||17,478
102,994|
||120,472|
## **CONTINUING OPERATIONS**
All income and expenditure has arisen from continuing activities.
The notes form part of these financial statements
Page 9
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **BALANCE SHEET 31 MARCH 2023**
|**2023**
**Unrestricted**
**fund**
Notes
**£**
**FIXED ASSETS**
Tangible assets
11
**23,499**
**CURRENT ASSETS**
Stocks
12
**142,550**
Debtors
13
**6,626**
Cash at bank and in hand
**13,846**
**163,022**
**CREDITORS**
Amounts falling due within one year
14
**(64,929)**
**NET CURRENT ASSETS**
**98,093**
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
**121,592**
**CREDITORS**
Amounts falling due after more than one
year
15
**(19,158)**
**NET ASSETS**
**102,434**
**FUNDS**
19
Unrestricted funds
**102,434**
**TOTAL FUNDS**
**102,434**|2022
Total
funds
£
31,790
133,525
8,954
21,497
163,976
(49,556)
114,420
146,210
(25,738)
120,472
120,472
120,472|
|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
Page 10
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **BALANCE SHEET - continued 31 MARCH 2023**
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 31 January 2024 and were signed on its behalf by:
J V Squires - Trustee
The notes form part of these financial statements
Page 11
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **CASH FLOW STATEMENT FOR THE YEAR ENDED 31 MARCH 2023**
|Notes
**Cash flows from operating activities**
Cash generated from operations
1
Interest paid
Interest element of hire purchase
payments paid
Net cash used in operating activities
**Cash flows from investing activities**
Purchase of tangible fixed assets
Net cash provided by/(used in) investing activities
**Cash flows from financing activities**
Capital repayments in year
Net cash (used in)/provided by financing activities
**Change in cash and cash equivalents**
**in the reporting period**
**Cash and cash equivalents at the**
**beginning of the reporting period**
**Cash and cash equivalents at the end**
**of the reporting period**|**2023**
**£**
**778**
**(413)**
**(1,233)**
**(868)**
**-**
**-**
**(6,783)**
**(6,783)**
**(7,651)**
**21,497**
**13,846**|2022
£
(29,991)
(196)
(379)
(30,566)
(19,995)
(19,995)
12,996
12,996
(37,565)
59,062
21,497|
|---|---|---|
The notes form part of these financial statements
Page 12
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE CASH FLOW STATEMENT FOR THE YEAR ENDED 31 MARCH 2023**
**1. RECONCILIATION OF NET (EXPENDITURE)/INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES**
## **2.**
|**ACTIVITIES**||||
|---|---|---|---|
|||**2023**|2022|
|||**£**|£|
|**Net (expenditure)/income for the reporting period**|**(as per the**|||
|**Statement of Financial Activities)**||**(18,038)**|17,478|
|**Adjustments for:**||||
|Depreciation charges||**8,291**|6,527|
|Interest paid||**413**|196|
|Interest element of hire purchase and finance lease rental payments||**1,233**|379|
|(Increase)/decrease in stocks||**(9,025)**|12,080|
|Decrease in debtors||**2,328**|2,513|
|Increase/(decrease) in creditors||**15,576**|(69,164)|
|**Net cash provided by/(used in) operations**||**778**|(29,991)|
|**ANALYSIS OF CHANGES IN NET DEBT**||||
||At 1.4.22|Cash flow|**At 31.3.23**|
||£|£|**£**|
|**Net cash**||||
|Cash at bank and in hand|**21,497**|**(7,651)**|**13,846**|
||**21,497**|**(7,651)**|**13,846**|
|**Debt**||||
|Finance leases|**(14,663)**|**2,783**|**(11,880)**|
|Debts falling due within 1 year|**(4,000)**|**-**|**(4,000)**|
|Debts falling due after 1 year|**(14,333)**|**4,000**|**(10,333)**|
||**(32,996)**|**6,783**|**(26,213)**|
|**Total**|**(11,499)**|**(868)**|**(12,367)**|
The notes form part of these financial statements
Page 13
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023**
## **1. ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
## **Going concern**
The financial statements have been prepared on a going concern basis.
The trustees have assessed whether the use of going concern is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern. The trustees make this assessment in respect of a period of one year from the date of approval of the financial statements.
At the balance sheet date the charity had surplus unrestricted fund of £102,434 (2022 - £120,472).
## **Income**
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. Income is derived from the provision of goods and services and is stated net of VAT.
## **Donations and legacies**
Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation is subject to conditions that require a level of performance by the charity before the charity is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is probable that these conditions will be fulfilled in the reporting period.
## **Investment income**
Interest on funds held on deposit is included when receivable and the amount can be reliably measured by the charity: this is normally upon notification of the interest paid or payable by the Bank.
## **Expenditure**
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
## **Raising funds**
These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities in raising funds.
## **Charitable activities**
Charities expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature.
## **Tangible fixed assets**
Individual fixed assets costing £500 or more are initially recorded at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment loss.
Page 14
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
## **1. ACCOUNTING POLICIES - continued**
## **Tangible fixed assets**
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
|**Asset Class**|**Depreciation method and rate**|
|---|---|
|Motor vehicles|20% on cost|
|Fixtures and fittings|15% on cost|
## **Stocks**
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Where practical, donated goods for resale are measured at fair value on initial recognition, which is the expected proceeds from sale less the expected costs of sale. Costs include cleaning and processing of goods into a saleable condition.
## **Taxation**
The charity is exempt from corporation tax on its charitable activities.
## **Fund accounting**
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
## **Pension costs and other post-retirement benefits**
The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
## **2. DONATIONS AND LEGACIES**
|**2.**|**DONATIONS AND LEGACIES**|||
|---|---|---|---|
|||**2023**|2022|
|||**£**|£|
||Gifts and donations|**8,220**|1,525|
|**3.**|**OTHER TRADING ACTIVITIES**|||
|||**2023**|2022|
|||**£**|£|
||Charity shop income|**296,705**|276,943|
Page 15
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
## **4. OTHER INCOME**
|Fundraising
Other income
Covid 19 Council Grants
JRS grant income|**2023**
**£**
**6,113**
**13,809**
**-**
**-**
**19,922**|2022
£
14,224
594
30,334
17,009|
|---|---|---|
|||62,161|
Fundraising income of £6,113 (2022 - £14,224) includes income received from fundraising events such as balls, charity sports days and other fundraising events held by the charity. Fundraising income also includes the money the charity receives from Skycycle Limited.
## **5. RAISING FUNDS**
## **Raising donations and legacies**
|Fundraising events - balls etc
**Other trading activities**
Purchases
Stock movement
Trustees' remuneration etc
Staff costs
Rent and rates
Light, heat, and insurance
Repairs and maintenance
Sundry
Travel and subsistence
Printing, postage, stationery
Depreciation
**Finance costs**
Bank charges and cardnet
Interest payable and similar charges
Aggregate amounts|**2023**
**£**
**4,767**
**2023**
**£**
**-**
**(9,025)**
**34,011**
**78,494**
**46,562**
**7,974**
**423**
**2,785**
**15,407**
**2,720**
**8,291**
**187,642**
**2023**
**£**
**4,468**
**1,646**
**6,114**
**198,523**|2022
£
7,193
2022
£
1,584
12,080
18,473
69,975
31,094
12,332
1,494
4,843
10,957
1,623
6,527|2022
£
7,193|
|---|---|---|---|
|||170,982||
|||2022
£
4,076
575
4,651
182,826|2022
£
4,076
575|
||||4,651|
Page 16
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
**NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
## **5. RAISING FUNDS - continued**
## **Allocation and apportionment of charity shop costs**
The charity shops running costs are apportioned as 50% fundraising and 50% charitable activity expenditure. A large proportion of shop space is used for upgraded information centres and for community support and advice.
## **Allocation and apportionment of staff costs**
Staff costs are apportioned as 50% other trading activities and 50% helpline, campaigning and raising awareness. This is to account for the time spent by staff offering support and advice in addition to running the charity shops.
## **6. CHARITABLE ACTIVITIES COSTS**
|Helpline costs
Campaigning and raising awareness
Activity support costs|Direct
Costs
£
**3,342**
**133,575**
**7,445**|
|---|---|
||**144,362**|
## **7. NET INCOME/(EXPENDITURE)**
Net income/(expenditure) is stated after charging/(crediting):
## **8.**
|Depreciation - owned assets
Independent examiners fee
**TRUSTEES' REMUNERATION AND BENEFITS**
Trustees' salaries
Trustees' fees
Trustees' social security|**2023**
**£**
**8,291**
**3,125**
**2023**
**£**
**32,496**
**-**
**1,515**
**34,011**|2022
£
6,527
2,950
2022
£
17,500
10,000
973|2022
£
6,527
2,950|
|---|---|---|---|
|||28,473||
Trustees' fees were paid to Wendy Watson for her role as helpline advisor in the prior year. Wendy Watson received £Nil (2022 - £10,000) trustees' fees while was working on a self-employed contractor basis.
From August 2021 Wendy Watson has been employed by the charity and received a salary of £32,496 (2022 - £17,500) for her position of helpline advisor .
No remuneration was paid to Wendy Watson for her role as trustee.
## **Trustees' expenses**
There were no trustees' expenses paid for the year ended 31 March 2023 nor for the year ended 31 March 2022.
Page 17
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
|**9.**
**STAFF COSTS**
Wages and salaries
Social security costs
Other pension costs
The average monthly number of employees during the year was as follows:
Average number
No employees received emoluments in excess of £60,000.
**10.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
Other trading activities
Other income
**Total**
**EXPENDITURE ON**
Raising funds
**Charitable activities**
Helpline costs
Campaigning and raising awareness
Activity support costs
**Total**
**NET INCOME**
**RECONCILIATION OF FUNDS**
Total funds brought forward
**TOTAL FUNDS CARRIED FORWARD**|**2023**
2022
**£**
£
**184,683**
164,647
**4,682**
2,486
**1,636**
1,293
**191,001**
168,426
**2023**
2022
**13**
16
Unrestricted
fund
£
1,525
276,943
62,161
340,629
182,826
4,159
117,138
19,028
323,151
17,478
102,994
120,472|
|---|---|
|||
Page 18
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
## **11. TANGIBLE FIXED ASSETS**
|Fixtures
and
Motor
fittings
vehicles
£
£
**COST**
At 1 April 2022 and 31 March 2023
**71,696**
**53,916**
**DEPRECIATION**
At 1 April 2022
**70,315**
**23,507**
Charge for year
**828**
**7,463**
At 31 March 2023
**71,143**
**30,970**
**NET BOOK VALUE**
At 31 March 2023
**553**
**22,946**
At 31 March 2022
1,381
30,409
The net carrying amount of tangible assets includes the following amounts in respect of
under finance leases and hire purchase contracts:
**2023**
**£**
Motor Vehicles
**13,996**
**12.**
**STOCKS**
**2023**
**£**
Stocks
**142,550**
**13.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
**2023**
**£**
Other debtors
**-**
Prepayments and accrued income
**6,626**
**6,626**|Fixtures
and
Motor
fittings
vehicles
£
£
**COST**
At 1 April 2022 and 31 March 2023
**71,696**
**53,916**
**DEPRECIATION**
At 1 April 2022
**70,315**
**23,507**
Charge for year
**828**
**7,463**
At 31 March 2023
**71,143**
**30,970**
**NET BOOK VALUE**
At 31 March 2023
**553**
**22,946**
At 31 March 2022
1,381
30,409
The net carrying amount of tangible assets includes the following amounts in respect of
under finance leases and hire purchase contracts:
**2023**
**£**
Motor Vehicles
**13,996**
**12.**
**STOCKS**
**2023**
**£**
Stocks
**142,550**
**13.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
**2023**
**£**
Other debtors
**-**
Prepayments and accrued income
**6,626**
**6,626**|Fixtures
and
Motor
fittings
vehicles
£
£
**COST**
At 1 April 2022 and 31 March 2023
**71,696**
**53,916**
**DEPRECIATION**
At 1 April 2022
**70,315**
**23,507**
Charge for year
**828**
**7,463**
At 31 March 2023
**71,143**
**30,970**
**NET BOOK VALUE**
At 31 March 2023
**553**
**22,946**
At 31 March 2022
1,381
30,409
The net carrying amount of tangible assets includes the following amounts in respect of
under finance leases and hire purchase contracts:
**2023**
**£**
Motor Vehicles
**13,996**
**12.**
**STOCKS**
**2023**
**£**
Stocks
**142,550**
**13.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
**2023**
**£**
Other debtors
**-**
Prepayments and accrued income
**6,626**
**6,626**|Totals
£
**125,612**
**93,822**
**8,291**
**102,113**
**23,499**
31,790
assets held|Totals
£
**125,612**
**93,822**
**8,291**
**102,113**
**23,499**
31,790
assets held|
|---|---|---|---|---|
||**2023**|||2022|
||**£**|||£|
||**13,996**|||17,995|
||||||
|||**2023**
**£**
**142,550**
**2023**
**£**
**-**
**6,626**
**6,626**||2022
£
133,525
2022
£
619
8,335
8,954|
||||||
Page 19
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
|**14.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Bank loans and overdrafts (see note 16)
Hire purchase (see note 17)
Trade creditors
Social security and other taxes
VAT
Wages and salaries control
Other creditors
Pensions control
Accruals
**15.**
**CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR**
Bank loans (see note 16)
Hire purchase (see note 17)
**16.**
**LOANS**
An analysis of the maturity of loans is given below:
Amounts falling due within one year on demand:
Bank loans
Amounts falling between one and two years:
Bank loans
Amounts falling due between two and five years:
Bank loans
**17.**
**LEASING AGREEMENTS**
Minimum lease payments fall due as follows:
Net obligations repayable:
Within one year
Between one and five years|**2023**
2022
**£**
£
**4,000**
4,000
**3,055**
3,258
**14,590**
8,057
**20,566**
11,228
**4,534**
5,481
**2,495**
-
**7,360**
9,056
**-**
266
**8,329**
8,210
**64,929**
49,556
**2023**
2022
**£**
£
**10,333**
14,333
**8,825**
11,405
**19,158**
25,738
**2023**
2022
**£**
£
**4,000**
4,000
**4,000**
4,000
**6,333**
10,333
**Hire purchase**
**contracts**
**2023**
2022
**£**
£
**3,055**
3,258
**8,825**
11,405
**11,880**
14,663|2022
£
4,000
3,258
8,057
11,228
5,481
-
9,056
266
8,210|
|---|---|---|
|||49,556|
|||2022
£
14,333
11,405|
|||25,738|
|||2022
£
4,000|
|||4,000|
|||10,333|
|||14,663|
Page 20
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
|**17.**|**LEASING AGREEMENTS - continued**||||
|---|---|---|---|---|
||||**Non-cancellable**||
||||**operating**|**leases**|
||||**2023**|2022|
||||**£**|£|
||Within one year||**-**|6,417|
|**18.**|**SECURED DEBTS**||||
||The following secured debts are included within creditors:||||
||||**2023**|2022|
||||**£**|£|
||Hire purchase contracts||**11,880**|14,663|
||Hire purchase creditors are secured on the assets acquired under the contract.||||
|**19.**|**MOVEMENT IN FUNDS**||||
||||Net||
||||movement|At|
|||At 1.4.22|in funds|31.3.23|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|**120,472**|**(18,038)**|**102,434**|
||**TOTAL FUNDS**|**120,472**|**(18,038)**|**102,434**|
||Net movement in funds, included in the above are as follows:||||
|||Incoming|Resources|Movement|
|||resources|expended|in funds|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|**324,847**|**(342,885)**|**(18,038)**|
||**TOTAL FUNDS**|**324,847**|**(342,885)**|**(18,038)**|
||**Comparatives for movement in funds**||||
||||Net||
||||movement|At|
|||At 1.4.21|in funds|31.3.22|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|102,994|17,478|120,472|
||**TOTAL FUNDS**|102,994|17,478|120,472|
Page 21
continued...
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2023**
## **19. MOVEMENT IN FUNDS - continued**
Comparative net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
**TOTAL FUNDS**|Incoming
resources
£
340,629
340,629|Resources
Movement
expended
in funds
£
£
(323,151)
17,478
(323,151)
17,478|
|---|---|---|
## **20. RELATED PARTY DISCLOSURES**
## **Wendy Watson**
(Wendy Watson is a subscriber member of the charity and trustee).
During the year, fees of £nil (2022 - £10,000) were paid to Wendy Watson for her role as helpline advisor.
Since August 2021 Wendy received a salary for her position as helpline advisor. During the year Wendy received wages of £32,496 (2022 - £17,500).
No remuneration was paid for her role as trustee.
As at 31 March 2023, Wendy Watson was owed £7,360 (2022 - £9,056) in respect of running costs paid on the charities behalf. This amount is repayable on demand.
## **21. CHARITY STATUS**
The charity is a company limited by guarantee and consequently does not have share capital. Each member is liable to contribute an amount not exceeding £10 towards the assets of the charity in the event of it being wound up.
Page 22
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2023**
|**INCOME AND ENDOWMENTS**
**Donations and legacies**
Gifts and donations
**Other trading activities**
Charity shop income
**Other income**
Fundraising
Other income
Covid 19 Council Grants
JRS grant income
**Total incoming resources**
**EXPENDITURE**
**Raising donations and legacies**
Fundraising events - balls etc
**Other trading activities**
Purchases
Trustees' salaries
Trustees' social security
Wages
Social security
Pensions
Rent and rates
Light, heat, and insurance
Repairs and maintenance
Sundry
Travel and subsistence
Printing, postage, stationery
Depreciation on fixtures and fittings
Depreciation on motor vehicles
Stock movement
**Finance costs**
Bank charges and cardnet
Bank loan interest
Hire purchase interest|2023
£
**8,220**
**296,705**
**6,113**
**13,809**
**-**
**-**
**19,922**
**324,847**
**4,767**
**-**
**32,496**
**1,515**
**76,093**
**1,583**
**818**
**46,562**
**7,974**
**423**
**2,785**
**15,407**
**2,720**
**828**
**7,463**
**(9,025)**
**187,642**
**4,468**
**413**
**1,233**
**6,114**|2022
£
1,525
276,943
14,224
594
30,334
17,009|
|---|---|---|
|||62,161|
|||340,629
7,193
1,584
17,500
973
68,573
756
646
31,094
12,332
1,494
4,843
10,957
1,623
1,063
5,464
12,080|
|||170,982
4,076
196
379|
|||4,651|
This page does not form part of the statutory financial statements
Page 23
**NATIONAL HEREDITARY BREAST CANCER HELPLINE**
## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2023**
|**DETAILED STATEMENT OF FINANCIAL ACTIVITIES**
**FOR THE YEAR ENDED 31 MARCH 2023**|||
|---|---|---|
|**Finance costs**
**Charitable activities**
Trustees' fees
Helpline/Campaigning Staff Wages
Helpline/Campaigning Staff social security
costs
Helpline/Campaigning Staff pensions costs
Rent and rates
Light, heat and insurance
Telephone
Campaigning raising awareness
Repairs and maintenance
Accountancy fees
Legal and professional fees
Bookkeeping services
Total resources expended
**Net (expenditure)/income**|2023
£
**-**
**76,094**
**1,584**
**818**
**46,562**
**7,974**
**3,342**
**120**
**423**
**3,125**
**-**
**4,320**
**144,362**
**342,885**
**(18,038)**|2022
£
10,000
68,574
757
647
31,094
12,332
4,159
2,240
1,494
2,950
1,238
4,840|
|||140,325|
|||323,151|
|||17,478|
This page does not form part of the statutory financial statements
Page 24